Home

mensual Previsión catalogar long term side effects of rituximab Suburbio Soledad láser

Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood

Both the rituximab dose and maintenance immunosuppression in  steroid-dependent/frequently-relapsing nephrotic syndrome have important  effects on outcomes - ScienceDirect
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect

Clinical review: Serious adverse events associated with the use of rituximab  - a critical care perspective | Critical Care | Full Text
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text

Addition of rituximab to fludarabine and cyclophosphamide in patients with  chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial -  The Lancet
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet

Cardiac side effect of rituximab Patil VB, Lunge SB, Doshi BR - Indian J  Drugs Dermatol
Cardiac side effect of rituximab Patil VB, Lunge SB, Doshi BR - Indian J Drugs Dermatol

Rituximab - Wikipedia
Rituximab - Wikipedia

Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today

Frontiers | Past, Present, and Future of Rituximab—The World's First  Oncology Monoclonal Antibody Therapy
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy

Lessons for rituximab therapy in patients with rheumatoid arthritis - The  Lancet Rheumatology
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology

Rituximab Treatment in Nephrotic Syndrome ESPN ppt download
Rituximab Treatment in Nephrotic Syndrome ESPN ppt download

Rituximab (Rituxan) Drug Information
Rituximab (Rituxan) Drug Information

GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology  Nurse Advisor
GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology Nurse Advisor

Rituxan Side Effects - HRF
Rituxan Side Effects - HRF

PV | RITUXAN® (rituximab) Safety Data
PV | RITUXAN® (rituximab) Safety Data

effects of rituximab in the patient described in this case report... |  Download Scientific Diagram
effects of rituximab in the patient described in this case report... | Download Scientific Diagram

Frequency of Rituximab related side effects. | Download Table
Frequency of Rituximab related side effects. | Download Table

First-line rituximab combined with short-term prednisone versus prednisone  alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre,  parallel-group, open-label randomised trial - The Lancet
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet

immediate and long-term side effects of rituximab administration | Download  Table
immediate and long-term side effects of rituximab administration | Download Table

Safety and efficacy of rituximab versus dimethyl fumarate in patients with  relapsing-remitting multiple sclerosis or clinically isolated syndrome in  Sweden: a rater-blinded, phase 3, randomised controlled trial - The Lancet  Neurology
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial - The Lancet Neurology

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results  from the International Autoimmune Hepatitis Group - ScienceDirect
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group - ScienceDirect

Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing  COVID-19 Infection to Relapse | The Permanente Journal
Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse | The Permanente Journal

Rituximab in the treatment of skin diseases Rajagopalan M, Vasani R -  Indian J Drugs Dermatol
Rituximab in the treatment of skin diseases Rajagopalan M, Vasani R - Indian J Drugs Dermatol

The importance of continuing with RITUXAN® (rituximab) for RA Patients
The importance of continuing with RITUXAN® (rituximab) for RA Patients

Frontiers | Past, Present, and Future of Rituximab—The World's First  Oncology Monoclonal Antibody Therapy
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy

Rituximab therapy in nephrotic syndrome: implications for patients'  management | Nature Reviews Nephrology
Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology